Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines

Japanese Journal of Cancer Research

Volumn 87, Issue 11, 1996, Pages 1153-1159

  Tamura, Gen ^a   Sakata, Ken ^a   Nishizuka, Satoshi ^a   Maesawa, Chihaya ^a   Suzuki, Yasushi ^a   Iwaya, Takeshi ^a   Terashima, Masanori ^a   Saito, Kazuyoshi ^a   Satodate, Ryoichi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

E cadherin; Gastric carcinoma; Gene mutation; Loss of heterozygosity

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CLINICAL ARTICLE; CONTROLLED STUDY; EXON; GENE DELETION; GENE LOSS; GENE MUTATION; GENE REPRESSION; HUMAN; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNET RING CARCINOMA; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA;

EID: 0029957442     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb03125.x     Document Type: Article

References (29)

1. Shimoyama, Y. and Hirohashi, S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res., 51, 2185-2192 (1991).
2. Tahara, E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol., 119, 265-272 (1993).
3. Tamura, G., Kihana, T., Nomura, K., Terada, M., Sugimura, T. and Hirohashi, S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res., 51, 3056-3058 (1991).
4. Tamura, G., Maesawa, C., Suzuki, Y., Ogasawara, S., Terashima, M. and Satodate, R. Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn. J. Cancer Res., 84, 1015-1018 (1993).
5. McKie, A. B., Filipe, M. I. and Lemoine, N. R. Abnormalities affecting the APC and MCC tumor suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int. J. Cancer, 55, 598-603 (1993).
6. Maesawa, C., Tamura, G., Suzuki, Y., Ogasawara, S., Sakata, K., Kashiwaba, M. and Satodate, R. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J. Pathol., 176, 249-258 (1995).
7. Coman, D. R. The invasive character of cancer growth. Am. J. Med. Sci., 211, 257-260 (1946).
8. Coman, D. R. Mechanism of the invasiveness of cancer. Science, 105, 347-348 (1947).
9. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science, 251, 1451-1455 (1991).
10. Mayer, B., Johnson, J. P., Letil, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W. and Funke, I. E-Cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res., 53, 1690-1695 (1993).
11. Schipper, J. H., Frixen, U. H., Behrens, J., Unger, A., Jahnke, K. and Birchmeier, W. E-Cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res., 51, 6328-6337 (1991).
12. Shiozaki, H., Tahara, H., Oka, H., Miyata, M., Kobayashi, K., Tamura, S., Iihara, K., Doki, Y., Hirano, S., Takeichi, M. and Mori, T. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am. J. Pathol., 139, 17-23 (1991).
13. Rimm, D. L., Sinard, J. H. and Morrow, J. S. Reduced α-catenin and E-cadherin expression in breast cancer. Lab. Invest., 72, 506-512 (1995).
14. Oda, T., Kanai, Y., Oyama, T., Yoshiura, K., Shimoyama, Y., Birchmeier, W., Sugimura, T. and Hirohashi, S. E-Cadherin gene mutations in human gastric carcinoma cell lines. Proc. Natl. Acad. Sci. USA, 91, 1858-1862 (1994).
15. Becker, K.-F., Atkinson, M. J., Reich, U., Becker, I., Nekarda, H., Siewert, J. R. and Höfler, H. E-Cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res., 54, 3845-3852 (1994).
16. Becker, K.-F. and Höfler, H. Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J. Natl. Cancer Inst., 87, 1082-1084 (1995).
17. Tamura, G., Sakata, K., Maesawa, C., Suzuki, Y., Terashima, M., Satoh, K., Sekiyama, S., Suzuki, A., Eda, Y. and Satodate, R. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res., 55, 1933-1936 (1995).
18. Bussemakers, M. J. G., van Bokhoven, A., Mees, S. G. M., Kemler, R. and Schalken, J. A. Molecular cloning and characterization of the E-cadherin cDNA. Mol. Biol. Reports, 17, 123-128 (1993).
19. Tamura, G., Maesawa, C., Suzuki, Y., Kashiwaba, M., Ishida, M., Saito, K. and Satodate, R. Improved detection of loss of heterozygosity at retinoblastoma gene locus in human breast carcinoma. Pathol. Int., 44, 34-38 (1994).
20. Nagafuchi, A. and Tsukita, S. The loss of expression of α-catenin, the 102 kD cadherin associated protein, in central nervous tissues during development. Dev. Growth Differ., 36, 59-71 (1994).
21. Herrenknecht, K., Ozawa, M., Eckerkorn, C., Lottspeich, F., Lenter, M. and Kemler, R. The uvomorulin-anchorage protein α catenin is a vinculin homologue. Proc. Natl. Acad. Sci. USA, 88, 9156-9160 (1990).
22. Su, L.-K., Vogelstein, B. and Kinzler, K. W. Association of the APC tumor suppressor protein with catenin. Science, 262, 1734-1737 (1993).
23. Hoschuetzky, H., Aberle, H. and Kemler, R. β-Catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor. J. Cell Biol., 127, 1375-1380 (1994).
24. Ochiai, A., Akimoto, S., Kanai, Y., Shibata, T., Oyama, T. and Hirohashi, S. c-erb B-2 gene product associates with catenins in human cancer cells. Biochem. Biophys. Res. Commun., 205, 73-78 (1994).
25. Candidus, S., Bischoff, P., Becker, K.-F. and Höfler, H. No evidence for mutations in the α- and β-catenin genes in human gastric and breast carcinomas. Cancer Res., 56, 49-52 (1996).
26. Yoshiura, K., Kanai, Y., Ochiai, A., Shimoyama, Y., Sugimura, T. and Hirohashi, S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA, 92, 7416-7419 (1995).
27. Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D.-S., Gnarra, J. R., Linehan, W. M. and Baylin, S. B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91, 9700-9704 (1994).
28. Lee, W.-H., Morton, R. A., Epstein, J. I., Brooks, J. D., Campbell, P. A., Bova, G. S., Hsieh, W.-S., Isaacs, W. B. and Nelson, W. G. Cytidine methylation of regulatory sequences near the π-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc. Natl. Acad. Sci. USA, 91, 11733-11737 (1994).
29. Herman, J. G., Merlo, A., Mao, L., Lapidus, R. G., Issa, J.-P. J., Davidson, N. E., Sidransky, D. and Baylin, S. B. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530 (1995).